News & Updates

San Antonio Breast Cancer Symposium

This multicenter phase III study was designed to evaluate the non-inferiority of efficacy of Genexol®-PM compared to conventional CrEL-based paclitaxel

Primary Purpose

Comparative analysis of objective response rates of Genexol®-PM Injection and conventional paclitaxel with Cremophor EL

Secondary Purpose

  1. Efficacy Comparison of Genexol®-PM Injection and conventional paclitaxel with Cremophor EL
    • Overall Survival
    • Progress Free Survival
    • Time to Tumor Progression
  2. Safety and toxicity when Genexol®-PM Injection and conventional paclitaxel with Cremophor EL are administered

 


... Click Here to view presentation

Brand Name: PAXUS™ PM (South East Asia), GENEXOL® PM (Korea & other territories)